RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Epidemiology and scenario simulations of the Middle East Respiratory Syndrome Corona Virus (MERS-CoV) disease spread and control for dromedary camels in United Arab Emirates (UAE)
Ali, M. M., Fathelrahman, E., El Awad, A. I., Eltahir, Y. M., Osman, R., El-Khatib, Y., AlRifai, R. H., El Sadig, M., Khalafalla, A. I., & Reeves, A. (2024). Epidemiology and scenario simulations of the Middle East Respiratory Syndrome Corona Virus (MERS-CoV) disease spread and control for dromedary camels in United Arab Emirates (UAE). Animals, 14(3), Article 362. https://doi.org/10.3390/ani14030362
Middle East Respiratory Syndrome (MERS-CoV) is a coronavirus-caused viral respiratory infection initially detected in Saudi Arabia in 2012. In UAE, high seroprevalence (97.1) of MERS-CoV in camels was reported in several Emirate of Abu Dhabi studies, including camels in zoos, public escorts, and slaughterhouses. The objectives of this research include simulation of MERS-CoV spread using a customized animal disease spread model (i.e., customized stochastic model for the UAE; analyzing the MERS-CoV spread and prevalence based on camels age groups and identifying the optimum control MERS-CoV strategy. This study found that controlling animal mobility is the best management technique for minimizing epidemic length and the number of affected farms. This study also found that disease dissemination differs amongst camels of three ages: camel kids under the age of one, young camels aged one to four, and adult camels aged four and up; because of their immunological state, kids, as well as adults, had greater infection rates. To save immunization costs, it is advised that certain age groups be targeted and that intense ad hoc unexpected vaccinations be avoided. According to the study, choosing the best technique must consider both efficacy and cost.